JPMorgan Lowers GSK Price Target, Maintains Underweight Rating
GSK(US:GSK) Yahoo Finance·2025-11-20 03:09GSK plc (NYSE:GSK) is included among the 12 Best European Dividend Stocks to Buy Now. JPMorgan Lowers GSK Price Target, Maintains Underweight Rating Photo by Annie Spratt on Unsplash On October 31, JPMorgan lowered its price target on GSK plc (NYSE:GSK) to 1,440 GBp from 1,550 GBp while maintaining an Underweight rating on the stock, according to a report by The Fly. GSK plc (NYSE:GSK) shares have risen nearly 40% since the start of 2025, driven by strong third-quarter results and an imp ...